Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "686e5df44c01bda1661052f0",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ALFUGEM T 2.5/10",
"description": "ALFUGEM T 2.5/10 is a scientifically formulated dual-action oral tablet that combines Alfuzosin 2.5 mg and Tadalafil 10 mg. This unique combination is primarily used for the treatment of benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) in men. By blending a selective alpha-blocker (Alfuzosin) with a phosphodiesterase-5 (PDE5) inhibitor (Tadalafil), ALFUGEM T 2.5/10 offers an effective solution for patients who suffer from both urological conditions.\n\nThe combination of alfuzosin and tadalafil has been shown to have an additive relaxant effect on human detrusor and prostatic tissues in vitro, enhancing urinary flow and improving sexual function.\n\nWhat is ALFUGEM T 2.5/10?\nALFUGEM T 2.5/10 is a fixed-dose combination tablet that contains two active ingredients:\n\nAlfuzosin (2.5 mg) – an alpha-1 adrenergic receptor blocker that relaxes the muscles in the prostate and bladder neck.\n\nTadalafil (10 mg) – a PDE5 inhibitor that increases blood flow to the penis and also helps relax the smooth muscles in the prostate and bladder.\n\nTogether, they help relieve lower urinary tract symptoms (LUTS) associated with BPH and improve erectile function in men.\n\nUses of ALFUGEM T 2.5/10:\nTreatment of Benign Prostatic Hyperplasia (BPH)\n\nRelief of lower urinary tract symptoms (LUTS) such as weak stream, urgency, and incomplete bladder emptying\n\nManagement of erectile dysfunction (ED) in men\n\nMay be beneficial for patients with both BPH and ED as a once-daily treatment\n\nHow Does ALFUGEM T 2.5/10 Work?\nAlfuzosin works by blocking alpha-1 receptors in the prostate and bladder, leading to relaxation of smooth muscle and improved urine flow.\n\nTadalafil enhances nitric oxide activity, leading to vasodilation in the penile tissues and also relaxes the lower urinary tract muscles.\n\nThe additive relaxant effect of this combination on the prostate and bladder tissues helps improve both urinary and sexual symptoms.\n\nSide Effects of ALFUGEM T 2.5/10:\nLike all medications, ALFUGEM T 2.5/10 may cause some side effects. Common side effects include:\n\nDizziness or lightheadedness\n\nHeadache\n\nBack pain or muscle aches\n\nNasal congestion\n\nIndigestion\n\nFlushing\n\nLow blood pressure (hypotension) in some cases\n\nRare but serious side effects may include:\n\nFainting or severe dizziness\n\nPriapism (prolonged or painful erection)\n\nVision changes or sudden vision loss\n\nChest pain or irregular heartbeat\n\nPrecautions Before Using ALFUGEM T 2.5/10:\nConsult your doctor before use if you have a history of heart disease, liver/kidney problems, or hypotension.\n\nAvoid activities like driving or operating machinery if you feel dizzy after taking the tablet.\n\nDo not take with other PDE5 inhibitors or alpha-blockers unless prescribed.\n\nLimit alcohol intake, as it can increase the risk of dizziness or low blood pressure.\n\nNot recommended for use in women or children.\n\nDrug Interactions – What Drugs Interact with ALFUGEM T 2.5/10?\nCertain drugs may interact with ALFUGEM T 2.5/10 and affect its effectiveness or increase the risk of side effects:\n\nAvoid or use with caution:\n\nNitrates (e.g., nitroglycerin) – can cause dangerous drops in blood pressure\n\nOther alpha-blockers – increased risk of hypotension\n\nAntifungals (e.g., ketoconazole, itraconazole)\n\nHIV protease inhibitors (e.g., ritonavir)\n\nAntibiotics (e.g., erythromycin, clarithromycin)\n\nBlood pressure medications – may enhance hypotensive effect\n\nGrapefruit juice – can alter the drug metabolism\n\nAlways inform your doctor about all the medications and supplements you are taking.\n\nConclusion:\nALFUGEM T 2.5/10 offers a comprehensive dual-action approach to managing two common male conditions – BPH and ED. With the clinically proven benefits of alfuzosin and tadalafil, this medication not only improves urinary flow and relieves prostate-related discomfort but also enhances sexual performance. Its synergistic relaxant effect on the bladder, prostate, and penile tissues makes it an ideal solution for men looking for convenience, efficacy, and improved quality of life.\n\nAlways follow your healthcare provider’s instructions for safe and effective use.",
"price": 310.0,
"discountamount": 93.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2143,
"imageuri": "https://productimages.withfloats.com/actual/686e5df9e9241987c803df61.png",
"tileimageuri": "https://productimages.withfloats.com/tile/686e5df9e9241987c803df61.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-09T12:17:56.999Z",
"updatedon": "2025-07-09T12:17:56.999Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/alfugem-t-2-5-10/2143",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "alfuzosin and tadalafil",
"category": "UROLOGYRANGE",
"tags": [
"alfuzosin and tadalafil"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666159468da3a81d5c6a08d8",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "PAFAGOLD M 500 ",
"description": "PAFAGOLD M 500 \nDapaflozin 10 mg + Metformin SR 500 mg\nIntroduction to PAFAGOLD M 500\nPAFAGOLD M 500 is a combination medication that includes Dapagliflozin 10mg and Metformin Hydrochloride Sustained Release (SR) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, PAFAGOLD M 500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This helps lower blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of PAFAGOLD M 500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps regulate fasting glucose levels by promoting glucose excretion through urine, while Metformin assists in lowering both fasting and postprandial (after-meal) glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD M 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD M 500\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD M 500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD M 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-m-500-134322",
"price": 180.0,
"discountamount": 54.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"Diet",
"body",
"Order",
"liver",
"EMAIL",
"urine",
"meals",
"water",
"action",
"amount",
"kidneys",
"Support",
"Overview",
"readings",
"calories",
"biguanide",
"one tablet",
"full glass",
"neuropathy",
"Dapaflozin",
"PAFAGOLD M",
"Guidelines",
"weight loss",
"information",
"Optimal Use",
"Adjustments",
"utilization",
"retinopathy",
"Introduction",
"Reduced Risk",
"Metformin SR",
"best results",
"sterisonline",
"Postprandial",
"sterispharma",
"heart failure",
"CALL/WHATSAPP",
"effectiveness",
"Consistent Use",
"treatment plan",
"sodium-glucose",
"Administration",
"dual mechanism",
"typical dosage",
"two medications",
"prolonged effect",
"Exercise Adjunct",
"SGLT2 inhibitors",
"excellent adjunct",
"glucose excretion",
"Weight Management",
"diabetic patients",
"multiple pathways",
"glucose regulation",
"Recommended Dosage",
"Dapagliflozin 10mg",
"additional benefits",
"insulin sensitivity",
"blood sugar control",
"healthcare provider",
"Diabetes Management",
"individual response",
"meal) glucose levels",
"cardiovascular disease",
"combination medication",
"long-term complications",
"lifestyle modifications",
"Fasting Glucose Control",
"cardiovascular benefits",
"type 2 diabetes mellitus",
"transporter-2) inhibitor",
"complementary mechanisms",
"cardiovascular protection",
"peripheral glucose uptake",
"stable blood sugar levels",
"Additional Health Benefits",
"hepatic glucose production",
"gastrointestinal discomfort",
"other cardiovascular events",
"sustained-release formulation",
"comprehensive glycemic control",
"Effective Blood Sugar Management",
"comprehensive blood sugar management",
"Metformin Hydrochloride Sustained Release"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1405,
"imageuri": "https://productimages.withfloats.com/actual/666159486030c166b1a8a9f2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666159486030c166b1a8a9f2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T06:37:58.426Z",
"updatedon": "2024-06-29T10:36:59.351Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/pafagold-m-500-/1405",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PAFAGOLD M 500 ",
"category": "DIABETIC RANGE",
"tags": [
"PAFAGOLD M 500",
"Dapaflozin 10 mg",
"Metformin SR 500 mg",
"Dapagliflozin 10 mg dosage",
"Dapagliflozin 10 mg price",
"Dapagliflozin 10 mg side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6660561aea22b014e8af1a73",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "PAFAGOLD M 1000 ",
"description": "PAFAGOLD M 1000 \nDapagliflozin , Metformin Hydrochloride\nIntroduction to PAFAGOLD M 1000\nPAFAGOLD M 1000 is a combination medication that includes Dapagliflozin and Metformin Hydrochloride. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, PAFAGOLD M 1000 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This helps lower blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of PAFAGOLD M 1000\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps regulate fasting glucose levels by promoting glucose excretion through urine, while Metformin assists in lowering both fasting and postprandial (after-meal) glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD M 1000 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD M 1000 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD M 1000\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD M 1000 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD M 1000 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-m-1000-134127",
"price": 195.0,
"discountamount": 58.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"Diet",
"body",
"liver",
"EMAIL",
"urine",
"Order",
"meals",
"water",
"amount",
"action",
"kidneys",
"Support",
"Overview",
"readings",
"calories",
"biguanide",
"full glass",
"Guidelines",
"neuropathy",
"PAFAGOLD M",
"one tablet",
"weight loss",
"Optimal Use",
"retinopathy",
"information",
"utilization",
"Adjustments",
"Introduction",
"sterispharma",
"best results",
"Reduced Risk",
"sterisonline",
"Postprandial",
"effectiveness",
"heart failure",
"CALL/WHATSAPP",
"Dapagliflozin",
"treatment plan",
"Consistent Use",
"sodium-glucose",
"Administration",
"dual mechanism",
"typical dosage",
"two medications",
"SGLT2 inhibitors",
"Exercise Adjunct",
"multiple pathways",
"excellent adjunct",
"Weight Management",
"diabetic patients",
"glucose excretion",
"Recommended Dosage",
"glucose regulation",
"Diabetes Management",
"additional benefits",
"blood sugar control",
"insulin sensitivity",
"healthcare provider",
"individual response",
"meal) glucose levels",
"cardiovascular disease",
"combination medication",
"long-term complications",
"lifestyle modifications",
"cardiovascular benefits",
"Fasting Glucose Control",
"Metformin Hydrochloride",
"type 2 diabetes mellitus",
"transporter-2) inhibitor",
"complementary mechanisms",
"peripheral glucose uptake",
"stable blood sugar levels",
"cardiovascular protection",
"hepatic glucose production",
"Additional Health Benefits",
"other cardiovascular events",
"gastrointestinal discomfort",
"comprehensive glycemic control",
"Effective Blood Sugar Management",
"comprehensive blood sugar management"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1391,
"imageuri": "https://productimages.withfloats.com/actual/6660561dc40ee9be0199735b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6660561dc40ee9be0199735b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T12:12:10.69Z",
"updatedon": "2024-06-29T11:03:11.406Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/pafagold-m-1000-/1391",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PAFAGOLD M 1000 ",
"category": "DIABETIC RANGE",
"tags": [
"PAFAGOLD M 1000",
"Dapagliflozin",
"Metformin Hydrochloride",
"Metformin hydrochloride uses",
"Metformin hydrochloride side effects",
"Metformin hydrochloride 1000 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666053368e599e12c0ea9a06",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "PAFAGOLD 5 ",
"description": "PAFAGOLD 5 \nDapagliflozin (5mg)\nIntroduction to PAFAGOLD 5\nPAFAGOLD 5 contains Dapagliflozin 5mg, a medication used primarily for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 (sodium-glucose co-transporter-2) inhibitors. It helps improve blood sugar control by preventing the kidneys from reabsorbing glucose back into the blood, allowing glucose to be excreted in the urine. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Dapagliflozin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 inhibitor that works by blocking the reabsorption of glucose in the kidneys. This leads to the excretion of excess glucose through urine, thereby lowering blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nMechanism of Action\nSGLT2 Inhibition: Dapagliflozin inhibits the SGLT2 protein in the kidneys, responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, Dapagliflozin ensures that excess glucose is excreted in the urine.\nBlood Sugar Reduction: This mechanism helps lower blood sugar levels, particularly fasting blood glucose levels, contributing to overall glycemic control.\nBenefits of PAFAGOLD 5\nEffective Blood Sugar Management\nFasting Glucose Control: PAFAGOLD 5 helps lower fasting blood glucose levels by promoting the excretion of glucose through urine.\nComprehensive Glycemic Control: By targeting glucose reabsorption in the kidneys, Dapagliflozin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD 5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD 5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD 5\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD 5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD 5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-5-134125",
"price": 120.0,
"discountamount": 36.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"diet",
"food",
"drugs",
"urine",
"class",
"EMAIL",
"Order",
"water",
"adults",
"Action",
"kidneys",
"Support",
"calories",
"PAFAGOLD",
"readings",
"Overview",
"excretion",
"same time",
"Guidelines",
"one tablet",
"full glass",
"neuropathy",
"Consistency",
"bloodstream",
"Adjustments",
"weight loss",
"information",
"retinopathy",
"combination",
"Optimal Use",
"Introduction",
"sterisonline",
"best results",
"sterispharma",
"Reduced Risk",
"heart failure",
"SGLT2 protein",
"CALL/WHATSAPP",
"Administration",
"sodium-glucose",
"typical dosage",
"treatment plan",
"Consistent Use",
"excess glucose",
"SGLT2 inhibitor",
"Exercise Adjunct",
"SGLT2 Inhibition",
"unique mechanism",
"Dapagliflozin 5mg",
"Weight Management",
"diabetic patients",
"excellent adjunct",
"Recommended Dosage",
"individual response",
"healthcare provider",
"blood sugar control",
"Diabetes Management",
"additional benefits",
"glucose reabsorption",
"blood glucose levels",
"Blood Sugar Reduction",
"cardiovascular disease",
"cardiovascular benefits",
"Fasting Glucose Control",
"lifestyle modifications",
"long-term complications",
"type 2 diabetes mellitus",
"overall glycemic control",
"transporter-2) inhibitors",
"cardiovascular protection",
"stable blood sugar levels",
"Additional Health Benefits",
"other diabetes medications",
"other cardiovascular events",
"Comprehensive Glycemic Control",
"Effective Blood Sugar Management",
"comprehensive blood sugar management"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1388,
"imageuri": "https://productimages.withfloats.com/actual/666053389917812fea5771aa.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666053389917812fea5771aa.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T11:59:50.713Z",
"updatedon": "2024-06-29T11:06:57.321Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/pafagold-5-/1388",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PAFAGOLD 5 ",
"category": "DIABETIC RANGE",
"tags": [
"PAFAGOLD 5",
"Dapagliflozin (5mg)",
"Dapagliflozin 5 mg uses",
"Dapagliflozin 5 mg price",
"Dapagliflozin 5 mg dosage",
"Dapagliflozin 5 mg substitute"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66605238a743fd235821fe26",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "PAFAGOLD 10 ",
"description": "PAFAGOLD 10 \nDapagliflozin (10mg)\nIntroduction to PAFAGOLD 10\nPAFAGOLD 10 contains Dapagliflozin 10mg, a medication primarily used for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 (sodium-glucose co-transporter-2) inhibitors. It helps improve blood sugar control by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Dapagliflozin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 inhibitor that works by blocking the reabsorption of glucose in the kidneys. This leads to the excretion of excess glucose through urine, thereby lowering blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nMechanism of Action\nSGLT2 Inhibition: Dapagliflozin inhibits the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, Dapagliflozin ensures that excess glucose is excreted in the urine.\nBlood Sugar Reduction: This mechanism helps lower blood sugar levels, particularly fasting blood glucose levels, contributing to overall glycemic control.\nBenefits of PAFAGOLD 10\nEffective Blood Sugar Management\nFasting Glucose Control: PAFAGOLD 10 helps lower fasting blood glucose levels by promoting the excretion of glucose through urine.\nComprehensive Glycemic Control: By targeting glucose reabsorption in the kidneys, Dapagliflozin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD 10 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD 10 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD 10\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD 10 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD 10 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-10-134126",
"price": 135.0,
"discountamount": 40.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"diet",
"food",
"drugs",
"urine",
"class",
"EMAIL",
"Order",
"water",
"adults",
"Action",
"kidneys",
"Support",
"calories",
"PAFAGOLD",
"readings",
"Overview",
"excretion",
"same time",
"Guidelines",
"one tablet",
"full glass",
"neuropathy",
"Consistency",
"bloodstream",
"Adjustments",
"weight loss",
"information",
"retinopathy",
"combination",
"Optimal Use",
"Introduction",
"sterisonline",
"best results",
"sterispharma",
"Reduced Risk",
"heart failure",
"SGLT2 protein",
"CALL/WHATSAPP",
"Administration",
"sodium-glucose",
"typical dosage",
"treatment plan",
"Consistent Use",
"excess glucose",
"SGLT2 inhibitor",
"Exercise Adjunct",
"SGLT2 Inhibition",
"unique mechanism",
"Weight Management",
"diabetic patients",
"excellent adjunct",
"Dapagliflozin 10mg",
"Recommended Dosage",
"individual response",
"healthcare provider",
"blood sugar control",
"Diabetes Management",
"additional benefits",
"glucose reabsorption",
"blood glucose levels",
"Blood Sugar Reduction",
"cardiovascular disease",
"cardiovascular benefits",
"Fasting Glucose Control",
"lifestyle modifications",
"long-term complications",
"type 2 diabetes mellitus",
"overall glycemic control",
"transporter-2) inhibitors",
"cardiovascular protection",
"stable blood sugar levels",
"Additional Health Benefits",
"other diabetes medications",
"other cardiovascular events",
"Comprehensive Glycemic Control",
"Effective Blood Sugar Management",
"comprehensive blood sugar management"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1386,
"imageuri": "https://productimages.withfloats.com/actual/6660523bc06ee12d88ce1635.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6660523bc06ee12d88ce1635.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T11:55:36.543Z",
"updatedon": "2024-06-29T11:14:01.571Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//pafagold-10-/1386",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PAFAGOLD 10 ",
"category": "DIABETIC RANGE",
"tags": [
"PAFAGOLD 10",
"Dapagliflozin (10mg)",
"Dapagliflozin 10mg uses",
"Dapagliflozin 10mg side effects",
"Dapagliflozin 10 mg price",
"Dapagliflozin 10 mg dosage"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66604eb566170d1ff8cb2c6a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "LINALIGLIP DAPA 5-10 ",
"description": "LINALIGLIP DAPA 5-10 \nLinagliptin 5 mg & Dapagliflozin 10 mg\nIntroduction to LINALIGLIP DAPA 5-10\nLINALIGLIP DAPA 5-10 is a combination medication that includes Linagliptin 5mg and Dapagliflozin 10mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Dapagliflozin, LINALIGLIP DAPA 5-10 provides comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Dapagliflozin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nBenefits of LINALIGLIP DAPA 5-10\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Dapagliflozin assists in lowering fasting glucose levels by promoting glucose excretion through urine.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP DAPA 5-10 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP DAPA 5-10 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use LINALIGLIP DAPA 5-10\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP DAPA 5-10 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow it whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP DAPA 5-10 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-dapa-5-10-134320",
"price": 245.0,
"discountamount": 73.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"food",
"Diet",
"Order",
"urine",
"EMAIL",
"meals",
"water",
"action",
"Support",
"kidneys",
"readings",
"Overview",
"calories",
"same time",
"full glass",
"one tablet",
"Guidelines",
"neuropathy",
"retinopathy",
"Consistency",
"Adjustments",
"information",
"Optimal Use",
"weight loss",
"best results",
"Reduced Risk",
"Postprandial",
"sterispharma",
"Introduction",
"sterisonline",
"Dapagliflozin",
"heart failure",
"CALL/WHATSAPP",
"dual mechanism",
"sodium-glucose",
"typical dosage",
"treatment plan",
"Administration",
"Consistent Use",
"insulin release",
"two medications",
"Linagliptin 5mg",
"LINALIGLIP DAPA",
"glucagon levels",
"linaliglip-dapa",
"SGLT2 inhibitors",
"Exercise Adjunct",
"glucose excretion",
"Weight Management",
"diabetic patients",
"excellent adjunct",
"multiple pathways",
"incretin hormones",
"Recommended Dosage",
"glucose regulation",
"individual response",
"Diabetes Management",
"additional benefits",
"healthcare provider",
"meal) glucose levels",
"blood glucose levels",
"cardiovascular disease",
"combination medication",
"Fasting Glucose Control",
"lifestyle modifications",
"long-term complications",
"cardiovascular benefits",
"type 2 diabetes mellitus",
"complementary mechanisms",
"transporter-2) inhibitor",
"cardiovascular protection",
"stable blood sugar levels",
"Additional Health Benefits",
"other cardiovascular events",
"overall blood sugar control",
"comprehensive glycemic control",
"Effective Blood Sugar Management",
"dipeptidyl peptidase-4) inhibitor",
"comprehensive blood sugar management"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1380,
"imageuri": "https://productimages.withfloats.com/actual/66604eb74f159c14e162af6b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66604eb74f159c14e162af6b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T11:40:37.381Z",
"updatedon": "2024-06-29T11:37:59.144Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-dapa-5-10-/1380",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "LINALIGLIP DAPA 5-10 ",
"category": "DIABETIC RANGE",
"tags": [
"LINALIGLIP DAPA 5-10",
"Linagliptin 5 mg",
"Dapagliflozin 10 mg",
"Dapagliflozin 10 mg dosage",
"Dapagliflozin 10 mg price",
"Dapagliflozin 10 mg Uses in Hindi",
"Dapagliflozin 10 mg side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "666036ade5c8fb18fc193640",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "GLIDAPAFLOZIN M 5/500 ",
"description": "GLIDAPAFLOZIN M 5/500 \nDapagliflozin (5mg), Metformin (500mg)\nIntroduction to GLIDAPAFLOZIN M 5/500\nGLIDAPAFLOZIN M 5/500 is a combination medication that includes Dapagliflozin 5mg and Metformin 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, GLIDAPAFLOZIN M 5/500 provides comprehensive glycemic control, helping patients achieve better blood sugar management and overall metabolic health.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of GLIDAPAFLOZIN M 5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps reduce both postprandial (after-meal) and fasting blood glucose levels by promoting glucose excretion through urine.\nBasal Glucose Control: Metformin helps maintain lower fasting blood sugar levels by improving insulin sensitivity and decreasing hepatic glucose production.\nWeight Management and Cardiovascular Benefits\nWeight Reduction: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nComprehensive Diabetes Management\nDual Mechanism: The combination of Dapagliflozin and Metformin offers a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nConvenience and Compliance: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLIDAPAFLOZIN M 5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of GLIDAPAFLOZIN M 5/500 is one tablet taken twice daily, usually with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLIDAPAFLOZIN M 5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-5-500-133424",
"price": 128.79,
"discountamount": 38.63,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"body",
"meal",
"risk",
"water",
"EMAIL",
"liver",
"Order",
"urine",
"amount",
"action",
"therapy",
"kidneys",
"readings",
"one pill",
"Overview",
"calories",
"Metformin",
"biguanide",
"full glass",
"Guidelines",
"one tablet",
"Compliance",
"utilization",
"weight loss",
"Adjustments",
"information",
"Optimal Use",
"Convenience",
"sterisonline",
"Introduction",
"sterispharma",
"Postprandial",
"best results",
"heart failure",
"effectiveness",
"CALL/WHATSAPP",
"Dapagliflozin",
"Consistent Use",
"sodium-glucose",
"Dual Mechanism",
"Administration",
"typical dosage",
"treatment plan",
"GLIDAPAFLOZIN M",
"SGLT2 inhibitors",
"Weight Reduction",
"Weight Management",
"diabetic patients",
"glucose excretion",
"multiple pathways",
"treatment regimen",
"Recommended Dosage",
"blood sugar levels",
"glucose regulation",
"insulin sensitivity",
"individual response",
"healthcare provider",
"blood glucose levels",
"Basal Glucose Control",
"combination medication",
"Fasting Glucose Control",
"Cardiovascular Benefits",
"transporter-2) inhibitor",
"complementary mechanisms",
"type 2 diabetes mellitus",
"overall metabolic health",
"Cardiovascular Protection",
"peripheral glucose uptake",
"hepatic glucose production",
"gastrointestinal discomfort",
"other cardiovascular events",
"comprehensive glycemic control",
"Effective Blood Sugar Management",
"Comprehensive Diabetes Management",
"two effective diabetes medications",
"comprehensive blood sugar management"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1359,
"imageuri": "https://productimages.withfloats.com/actual/666036b0487c46164ce21532.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666036b0487c46164ce21532.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T09:58:05.188Z",
"updatedon": "2024-06-29T12:36:58.891Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-5-500-/1359",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIDAPAFLOZIN M 5/500 ",
"category": "DIABETIC RANGE",
"tags": [
"GLIDAPAFLOZIN M 5/500",
"Dapagliflozin (5mg)",
"Metformin (500mg)",
"Dapagliflozin 5mg uses",
"Dapagliflozin 5 mg uses",
"Dapagliflozin 5 mg dosage",
"Dapagliflozin 5 mg heart failure"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "665dbb06dce9381dfcc553b6",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "DAPA VILDA 10/100 SR ",
"description": "DAPA VILDA 10/100 SR \nDapagliflozin (10mg), Vildagliptin SR (100mg)\nIntroduction to DAPA VILDA 10/100 SR\nDAPA VILDA 10/100 SR is a combination medication that includes Dapagliflozin 10mg and Vildagliptin 100mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Dapagliflozin and Vildagliptin work together to improve blood sugar control through complementary mechanisms, making this combination an effective treatment option for patients needing comprehensive glycemic management.\n\nWhat are Dapagliflozin and Vildagliptin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels.\n\nOverview of Vildagliptin\nVildagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of DAPA VILDA 10/100 SR\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Vildagliptin helps regulate postprandial (after-meal) glucose levels, while Dapagliflozin assists in lowering fasting glucose levels by promoting glucose excretion through urine.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nWeight Management and Cardiovascular Benefits\nWeight Reduction: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nConvenience and Compliance\nOnce-Daily Dosing: The sustained-release formulation of Vildagliptin allows for once-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use DAPA VILDA 10/100 SR\nDosage and Administration\nRecommended Dosage: The typical dosage of DAPA VILDA 10/100 SR is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food, preferably at the same time each day to maintain consistent blood levels of the medication. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take DAPA VILDA 10/100 SR regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/dapa-vilda-10-100-sr-134064",
"price": 210.0,
"discountamount": 63.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"body",
"food",
"risk",
"urine",
"EMAIL",
"Order",
"meals",
"water",
"action",
"kidneys",
"one pill",
"calories",
"readings",
"Overview",
"same time",
"full glass",
"Guidelines",
"one tablet",
"Optimal Use",
"Adjustments",
"information",
"weight loss",
"Convenience",
"Introduction",
"Daily Dosing",
"best results",
"sterisonline",
"sterispharma",
"Postprandial",
"CALL/WHATSAPP",
"heart failure",
"treatment plan",
"Administration",
"typical dosage",
"dual mechanism",
"Consistent Use",
"sodium-glucose",
"glucagon levels",
"two medications",
"insulin release",
"Vildagliptin SR",
"Weight Reduction",
"prolonged effect",
"SGLT2 inhibitors",
"diabetic patients",
"treatment regimen",
"Weight Management",
"glucose excretion",
"multiple pathways",
"Dapagliflozin 10mg",
"prescribed therapy",
"patient compliance",
"blood sugar levels",
"glucose regulation",
"Recommended Dosage",
"individual response",
"blood sugar control",
"healthcare provider",
"Reduced Pill Burden",
"meal) glucose levels",
"blood glucose levels",
"DAPA VILDA 10/100 SR",
"combination medication",
"Fasting Glucose Control",
"consistent blood levels",
"Cardiovascular Benefits",
"transporter-2) inhibitor",
"complementary mechanisms",
"type 2 diabetes mellitus",
"natural incretin hormones",
"Cardiovascular Protection",
"effective treatment option",
"other cardiovascular events",
"sustained-release formulation",
"Comprehensive Glycemic Control",
"Effective Blood Sugar Management",
"comprehensive glycemic management",
"dipeptidyl peptidase-4) inhibitor",
"sustained-release (SR) formulation",
"two effective diabetes medications",
"comprehensive blood sugar management"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1253,
"imageuri": "https://productimages.withfloats.com/actual/665dbb093b5550f17788eb4e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/665dbb093b5550f17788eb4e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-03T12:45:58.06Z",
"updatedon": "2024-06-03T12:45:58.06Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/dapa-vilda-10-100-sr-/1253",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DAPA VILDA 10/100 SR ",
"category": "DIABETIC RANGE",
"tags": null,
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68b6d892c8730ef2a3e86287",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "FABRICAL LIPO SYRUP",
"description": "Description: \nFABRICAL LIPO SYRUP is a scientifically formulated nutritional supplement that combines the power of Liposomal Calcium, Vitamin K2-7, and Vitamin D2. This unique formulation is designed to support bone strength, joint health, cardiovascular wellness, and overall immunity. The use of liposomal technology enhances absorption and bioavailability, ensuring that the body receives the maximum benefit from each nutrient.\n\nCalcium is essential for strong bones and teeth, Vitamin D2 improves calcium absorption, while Vitamin K2-7 directs calcium to bones and prevents it from depositing in arteries. Together, these nutrients provide a synergistic effect that goes beyond regular calcium supplements.\n\n \nUses of FABRICAL LIPO SYRUP\n \n\nFABRICAL LIPO SYRUP has multiple health benefits and is widely recommended for:\n\nBone Health – Helps in preventing osteoporosis, bone fragility, and fractures.\n\nJoint Strength – Supports healthy cartilage and mobility in adults and elderly.\n\nDental Health – Promotes stronger teeth and prevents calcium deficiency-related dental problems.\n\nCalcium Deficiency – Useful in conditions like hypocalcemia and during rapid growth phases in children.\n\nPost-Menopausal Women – Reduces risk of bone loss and osteoporosis after menopause.\n\nPregnancy & Lactation – Provides additional calcium and vitamin support for mother and baby.\n\nHeart & Vascular Health – Vitamin K2-7 prevents calcium deposition in arteries, promoting cardiovascular wellness.\n\nImmunity & Muscle Function – Vitamin D2 supports immune defense and muscle strength.\n\n \nSide Effects of FABRICAL LIPO SYRUP\n \n\nFABRICAL LIPO SYRUP is generally well-tolerated when taken as prescribed. However, some individuals may experience:\n\nMild stomach upset or nausea\n\nConstipation in some cases\n\nHeadache or fatigue (rare)\n\nExcessive intake may cause high calcium levels, leading to kidney discomfort or increased thirst\n\nSerious side effects are very rare. Patients should consult a doctor if they experience persistent or unusual symptoms.\n\n \nPrecautions Before Using FABRICAL LIPO SYRUP\n \n\nBefore starting FABRICAL LIPO SYRUP, it is important to follow some precautions:\n\nAllergy Check – Do not use if allergic to calcium, vitamin D, or vitamin K supplements.\n\nMedical Conditions – Patients with kidney disease, hypercalcemia, or heart conditions should consult a doctor before use.\n\nPregnancy & Lactation – Safe under medical supervision, but dosage must be recommended by a doctor.\n\nChildren & Elderly – Can be given under medical advice for bone health support.\n\nDosage Compliance – Do not exceed the recommended dose to avoid calcium overload.\n\n \nDrug Interactions of FABRICAL LIPO SYRUP\n \n\nFABRICAL LIPO SYRUP may interact with certain medications:\n\nAnticoagulants (Warfarin, etc.) – Vitamin K2-7 may reduce their effectiveness.\n\nThyroid Hormone (Levothyroxine) – Calcium may reduce absorption; take doses at least 4 hours apart.\n\nAntibiotics (Tetracyclines, Quinolones) – Calcium may interfere with absorption; spacing doses is advised.\n\nDiuretics – Some may increase calcium levels in the blood.\n\nAlways inform your doctor about all ongoing medications to avoid unwanted interactions.\n\n \nConclusion\n \n\nFABRICAL LIPO SYRUP is an advanced health supplement crafted with Liposomal Calcium, Vitamin K2-7, and Vitamin D2 to provide superior bone, joint, and cardiovascular health support. Unlike ordinary calcium supplements, this formulation ensures better absorption, correct calcium utilization, and overall wellness.\n\nIt is especially beneficial for children during growth, adults with calcium deficiency, post-menopausal women, elderly individuals prone to osteoporosis, and patients requiring additional bone and joint support. By combining modern liposomal technology with essential nutrients, FABRICAL LIPO SYRUP by Steris Healthcare stands as a reliable, safe, and effective choice for long-term health.\n\nChoosing FABRICAL LIPO SYRUP means choosing a healthier, stronger, and more active lifestyle with the trusted assurance of Steris Healthcare’s quality and commitment.",
"price": 205.0,
"discountamount": 61.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2172,
"imageuri": "https://productimages.withfloats.com/actual/68b6d8954d1092feddfacbc5.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b6d8954d1092feddfacbc5.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-02T11:44:18.672Z",
"updatedon": "2025-09-02T11:44:18.672Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/fabrical-lipo-syrup/2172",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "LIPOSOMAL CALCIUM VITAMIN K2-7 AND VITAMIN D2 SYRUP",
"category": "GENERAL RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}